HRTX news

Latest 1 stories · newest Jun 2, 2026

HRTX

U.S. District Court invalidates Heron's CINVANTI patents; company plans appeal

A Delaware federal court ruled that Heron Therapeutics' U.S. Patent Nos. 12,115,255 and 12,290,520 for CINVANTI injectable emulsion are invalid in litigation against Azurity Pharmaceuticals. The decision threatens Heron's intellectual property protection for a key product, though the company plans t…

Legal Jun 2, 2026 sentiment -0.75 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same HRTX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/HRTX/newsSTART FREE